Lm. Hurwitz et Pj. Casey, CAN PRENYLCYSTEINES BE EXPLOITED AS LIGANDS FOR MAMMALIAN MULTIDRUG-RESISTANCE TRANSPORTERS, Chemistry & biology, 4(10), 1997, pp. 711-715
The overexpression of specific transport proteins in the membrane of m
any cancer cells renders these cells resistant to many therapeutic dru
gs. Some lipid-modified cysteine compounds inhibit one drug-transporti
ng protein, indicating the potential of developing such compounds as t
herapeutic agents.